Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

China flag China · Delayed Price · Currency is CNY
28.65
-0.09 (-0.31%)
At close: Apr 29, 2026
47.15%
Market Cap 12.13B
Revenue (ttm) 674.49M
Net Income (ttm) 23.29M
Shares Out 423.51M
EPS (ttm) 0.05
PE Ratio 520.99
Forward PE n/a
Dividend 0.20 (0.70%)
Ex-Dividend Date May 27, 2025
Volume 3,041,354
Average Volume 4,669,416
Open 28.82
Previous Close 28.74
Day's Range 28.58 - 29.15
52-Week Range 19.41 - 42.26
Beta 0.34
RSI 51.68
Earnings Date Apr 28, 2026

About SHE:301263

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as ... [Read more]

Sector Healthcare
Founded 1999
Employees 1,081
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301263
Full Company Profile

Financial Performance

In 2024, SHE:301263's revenue was 721.03 million, a decrease of -5.23% compared to the previous year's 760.79 million. Earnings were 108.22 million, a decrease of -32.45%.

Financial Statements

News

There is no news available yet.